Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neurometrix Inc (NURO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 2,527
  • Shares Outstanding, K 1,270
  • Annual Sales, $ 12,030 K
  • Annual Income, $ -14,910 K
  • 36-Month Beta 0.49
  • Price/Sales 0.21
  • Price/Cash Flow 0.00
  • Price/Book 0.33

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.81 +9.94%
on 07/21/17
3.09 -35.60%
on 06/23/17
-0.84 (-29.68%)
since 06/21/17
3-Month
1.81 +9.94%
on 07/21/17
5.28 -62.31%
on 04/24/17
-3.37 (-62.87%)
since 04/21/17
52-Week
1.81 +9.94%
on 07/21/17
13.84 -85.62%
on 09/01/16
-11.77 (-85.54%)
since 07/21/16

Most Recent Stories

More News
NeuroMetrix Reports Q2 2017 Financial Results

--Quell device shipments of 20.1K and electrode reorders of 30.7K represent new quarterly highs

NURO : 1.99 (-1.49%)
NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock

NeuroMetrix, Inc. (NASDAQ: NURO) announced today that it has entered into a definitive securities purchase agreement with a healthcare dedicated institutional investor in connection with...

NURO : 1.99 (-1.49%)
NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics

NeuroMetrix, Inc. (Nasdaq: NURO) today reported that Michael MacDonald has been promoted to SVP and General Manager of Diagnostics. In this role, Mr. MacDonald will oversee the Company's...

NURO : 1.99 (-1.49%)
NeuroMetrix Provides Update on Quell Health Cloud Including Promotion of Dr. Xuan Kong to Chief Data Scientist

NeuroMetrix, Inc. (Nasdaq: NURO) today provided an update on its data science initiative and the related Quell(R) Health Cloud.

NURO : 1.99 (-1.49%)
NeuroMetrix Provides Update on Quell Wearable Pain Relief Clinical Program

NeuroMetrix, Inc. (Nasdaq: NURO) today provided an update on its Quell(R) clinical program. Quell is a wearable non-invasive neurostimulator that provides widespread analgesia for chronic...

NURO : 1.99 (-1.49%)
Today's Research Reports on Stocks to Watch: Cleantech Solutions and NeuroMetrix

NEW YORK, NY / ACCESSWIRE / June 14, 2017 / Cleantech Solutions saw some nice gains on Tuesday after the company announced a partnership agreement with Ecrent Capital Holdings. NeuroMetrix's shares saw...

CLNT : 4.09 (+0.49%)
NURO : 1.99 (-1.49%)
NeuroMetrix to Present at the Marcum Microcap Conference on June 16, 2017

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and CEO of NeuroMetrix, is scheduled to speak at the upcoming 2017 Marcum Microcap Conference at...

NURO : 1.99 (-1.49%)
NeuroMetrix Exhibits Quell Wearable Technology at 31st Annual SLEEP Meeting

NeuroMetrix, Inc. (Nasdaq: NURO) is showing Quell(R), its 100% drug-free Wearable Pain Relief Technology(TM) to sleep medicine professionals from around the world at SLEEP 2017,...

NURO : 1.99 (-1.49%)
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,656,070.

NURO : 1.99 (-1.49%)
NeuroMetrix Launches the LivingQuell Blog, a New Platform for Exploring Perspectives on Chronic Pain

NeuroMetrix, Inc. (Nasdaq: NURO) today announced the launch of LivingQuell, a blog that will serve as an online resource for people affected by chronic pain - as well as the rapidly...

NURO : 1.99 (-1.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes,...

See More

Support & Resistance

2nd Resistance Point 2.29
1st Resistance Point 2.14
Last Price 1.99
1st Support Level 1.82
2nd Support Level 1.66

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.